These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 1889304

  • 1. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM, Maskell JP, Sehgal SC, Williams JD.
    Infection; 1989; 17(3):165-7. PubMed ID: 2737760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
    Cornaglia G, Ligozzi M, Pelosi E, Canepari P, Fontana R.
    J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
    [Abstract] [Full Text] [Related]

  • 9. Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.
    Qadri SM, Ueno Y, Postle G, Tullo D, San Pedro J.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):372-7. PubMed ID: 8394816
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activity of lomefloxacin as compared with ciprofloxacin.
    Inderlied CB, Lancero MG, Bermudez LM, Young LS.
    Diagn Microbiol Infect Dis; 1989 May; 12(3 Suppl):17S-20S. PubMed ID: 2791493
    [Abstract] [Full Text] [Related]

  • 14. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 May; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
    Visser MR, Rozenberg-Arska M, Beumer H, Hoepelman IM, Verhoef J.
    Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
    Molinari G, Bandelloni R, Paglia P, Debbia E, Schito GC.
    Diagn Microbiol Infect Dis; 1989 May; 12(3 Suppl):53S-56S. PubMed ID: 2791499
    [Abstract] [Full Text] [Related]

  • 19. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D, Grabowski M, Koss J, Weselowski V.
    Diagn Microbiol Infect Dis; 1989 May; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.